Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68


Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.

Chen BT, Sethi SK, Jin T, Patel SK, Ye N, Sun CL, Rockne RC, Haacke EM, Root JC, Saykin AJ, Ahles TA, Holodny AI, Prakash N, Mortimer J, Waisman J, Yuan Y, Somlo G, Li D, Yang R, Tan H, Katheria V, Morrison R, Hurria A.

Breast Cancer Res. 2018 May 2;20(1):38. doi: 10.1186/s13058-018-0965-3.


Cognitive Impairment Associated with Cancer: A Brief Review.

Pendergrass JC, Targum SD, Harrison JE.

Innov Clin Neurosci. 2018 Feb 1;15(1-2):36-44. Review.


Structural MRI research in patients with nasopharyngeal carcinoma following radiotherapy: A DTI and VBM study.

Leng X, Fang P, Lin H, An J, Tan X, Zhang C, Wu D, Shen W, Qiu S.

Oncol Lett. 2017 Nov;14(5):6091-6096. doi: 10.3892/ol.2017.6968. Epub 2017 Sep 15.


Association of cancer and Alzheimer's disease risk in a national cohort of veterans.

Frain L, Swanson D, Cho K, Gagnon D, Lu KP, Betensky RA, Driver J.

Alzheimers Dement. 2017 Dec;13(12):1364-1370. doi: 10.1016/j.jalz.2017.04.012. Epub 2017 Jul 12.


Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults.

Vega JN, Dumas J, Newhouse PA.

Am J Geriatr Psychiatry. 2017 Dec;25(12):1415-1426. doi: 10.1016/j.jagp.2017.04.001. Epub 2017 Apr 6. Review.


A systemic literature review of neuroimaging studies in women with breast cancer treated with adjuvant chemotherapy.

Andryszak P, Wiłkość M, Izdebski P, Żurawski B.

Contemp Oncol (Pozn). 2017;21(1):6-15. doi: 10.5114/wo.2017.66652. Epub 2017 Mar 22. Review.


Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns.

Apple AC, Ryals AJ, Alpert KI, Wagner LI, Shih PA, Dokucu M, Cella D, Penedo FJ, Voss JL, Wang L.

Neuroimage Clin. 2017 Mar 16;14:685-691. doi: 10.1016/j.nicl.2017.03.004. eCollection 2017.


Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy.

Lin J, Lv X, Niu M, Liu L, Chen J, Xie F, Zhong M, Qiu S, Li L, Huang R.

Neuroimage Clin. 2017 Mar 2;14:610-621. doi: 10.1016/j.nicl.2017.02.025. eCollection 2017.


TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin.

Moruno-Manchon JF, Uzor NE, Kesler SR, Wefel JS, Townley DM, Nagaraja AS, Pradeep S, Mangala LS, Sood AK, Tsvetkov AS.

Aging (Albany NY). 2016 Dec 16;8(12):3507-3519. doi: 10.18632/aging.101144.


Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats.

Lomeli N, Di K, Czerniawski J, Guzowski JF, Bota DA.

Free Radic Biol Med. 2017 Jan;102:274-286. doi: 10.1016/j.freeradbiomed.2016.11.046. Epub 2016 Nov 28.


Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study.

Correa DD, Root JC, Kryza-Lacombe M, Mehta M, Karimi S, Hensley ML, Relkin N.

Brain Imaging Behav. 2017 Dec;11(6):1652-1663. doi: 10.1007/s11682-016-9608-4.


Postoperative hormonal therapy prevents recovery of neurological damage after surgery in patients with breast cancer.

Sekiguchi A, Sato C, Matsudaira I, Kotozaki Y, Nouchi R, Takeuchi H, Kawai M, Tada H, Ishida T, Taki Y, Ohuchi N, Kawashima R.

Sci Rep. 2016 Oct 6;6:34671. doi: 10.1038/srep34671.


PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain.

Lim I, Joung HY, Yu AR, Shim I, Kim JS.

Biomed Res Int. 2016;2016:6945415. doi: 10.1155/2016/6945415. Epub 2016 Jul 31.


The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain".

Gaman AM, Uzoni A, Popa-Wagner A, Andrei A, Petcu EB.

Aging Dis. 2016 May 27;7(3):307-17. doi: 10.14336/AD.2015.1022. eCollection 2016 May. Review.


Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons.

Manchon JF, Dabaghian Y, Uzor NE, Kesler SR, Wefel JS, Tsvetkov AS.

Sci Rep. 2016 May 11;6:25705. doi: 10.1038/srep25705.


The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study.

Lyon DE, Cohen R, Chen H, Kelly DL, Starkweather A, Ahn HC, Jackson-Cook CK.

J Cancer Res Clin Oncol. 2016 Jul;142(7):1461-74. doi: 10.1007/s00432-016-2163-y. Epub 2016 Apr 21.


Imaging Brain Networks After Cancer and Chemotherapy: Advances Toward Etiology and Unanswered Questions.

Nudelman KN, McDonald BC, Saykin AJ.

JAMA Oncol. 2016 Feb;2(2):174-6. doi: 10.1001/jamaoncol.2015.4551. No abstract available.


Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.

Kesler SR, Blayney DW.

JAMA Oncol. 2016 Feb;2(2):185-92. doi: 10.1001/jamaoncol.2015.4333.


Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls.

Wang L, Apple AC, Schroeder MP, Ryals AJ, Voss JL, Gitelman D, Sweet JJ, Butt ZA, Cella D, Wagner LI.

Cancer. 2016 Jan 15;122(2):258-68. doi: 10.1002/cncr.29737. Epub 2015 Oct 20.


Higher cardiorespiratory fitness levels are associated with greater hippocampal volume in breast cancer survivors.

Chaddock-Heyman L, Mackenzie MJ, Zuniga K, Cooke GE, Awick E, Roberts S, Erickson KI, McAuley E, Kramer AF.

Front Hum Neurosci. 2015 Aug 26;9:465. doi: 10.3389/fnhum.2015.00465. eCollection 2015.

Supplemental Content

Support Center